MedPath

CORNEAL CONSULTANTS OF INDIANA, P.C.

CORNEAL CONSULTANTS OF INDIANA, P.C. logo
🇺🇸United States
Ownership
Private
Established
1983-01-01
Employees
11
Market Cap
-
Website
https://pricevisiongroup.com

Loteprednol Etabonate 0.25% for Prevention of Cornea Transplant Rejection

Phase 4
Completed
Conditions
Corneal Endothelial Dystrophy
Corneal Edema
Interventions
First Posted Date
2021-11-29
Last Posted Date
2024-08-14
Lead Sponsor
Price Vision Group
Target Recruit Count
70
Registration Number
NCT05136443
Locations
🇺🇸

Price Vision Group, Indianapolis, Indiana, United States

Corneal Crosslinking for Treatment of Corneal Neovascularization

Phase 2
Recruiting
Conditions
Corneal Neovascularization
Interventions
Combination Product: 10 minute photoactivation of riboflavin 0.1%
Combination Product: 30 minute photoactivation of riboflavin 0.1%
First Posted Date
2021-03-08
Last Posted Date
2024-07-24
Lead Sponsor
Price Vision Group
Target Recruit Count
62
Registration Number
NCT04787471
Locations
🇺🇸

Price Vision Group, Indianapolis, Indiana, United States

Effect of Xen Implantation on the Aqueous Humor Proteome

Terminated
Conditions
Primary Open Angle Glaucoma
Interventions
Device: Xen
Device: Aqueous shunt
First Posted Date
2019-10-28
Last Posted Date
2022-03-03
Lead Sponsor
Price Vision Group
Target Recruit Count
3
Registration Number
NCT04141865
Locations
🇺🇸

Price Vision Group, Indianapolis, Indiana, United States

Rhopressa for Corneal Edema Associated With Fuchs Dystrophy

Phase 2
Completed
Conditions
Fuchs Endothelial Dystrophy
Interventions
First Posted Date
2019-08-09
Last Posted Date
2021-10-19
Lead Sponsor
Price Vision Group
Target Recruit Count
29
Registration Number
NCT04051463
Locations
🇺🇸

Price Vision Group, Indianapolis, Indiana, United States

Trial of Netarsudil for Acceleration of Corneal Endothelial Restoration

Phase 2
Terminated
Conditions
Fuchs' Endothelial Dystrophy
Interventions
Drug: Placebo
First Posted Date
2019-06-03
Last Posted Date
2023-02-06
Lead Sponsor
Price Vision Group
Target Recruit Count
19
Registration Number
NCT03971357
Locations
🇺🇸

Price Vision Group, Indianapolis, Indiana, United States

Comparison of Standard vs. Accelerated Corneal Crosslinking

Phase 2
Recruiting
Conditions
Ectasia Corneal
Keratoconus
Interventions
Combination Product: Riboflavin 0.1%
First Posted Date
2019-04-22
Last Posted Date
2024-07-24
Lead Sponsor
Price Vision Group
Target Recruit Count
510
Registration Number
NCT03922542
Locations
🇺🇸

Price Vision Group, Indianapolis, Indiana, United States

Effect of TrueTear Corneal Surface Imaging

Not Applicable
Completed
Conditions
Cataract
Myopia
Interventions
Device: TrueTear
First Posted Date
2018-08-20
Last Posted Date
2020-08-11
Lead Sponsor
Price Vision Group
Target Recruit Count
45
Registration Number
NCT03637348
Locations
🇺🇸

Price Vision Group, Indianapolis, Indiana, United States

Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK)

Phase 2
Completed
Conditions
Bullous Keratopathy
Fuchs' Dystrophy
Interventions
First Posted Date
2011-10-07
Last Posted Date
2014-09-03
Lead Sponsor
Price Vision Group
Target Recruit Count
264
Registration Number
NCT01448213
Locations
🇺🇸

Price Vision Group, Indianapolis, Indiana, United States

🇩🇪

University of Erlangen, Erlangen, Germany

Corneal Crosslinking in Patients With Keratoconus and Post-Refractive Ectasia

Phase 2
Completed
Conditions
Keratoconus
Post-Refractive Ectasia
Interventions
Device: UVX light
First Posted Date
2010-06-14
Last Posted Date
2018-06-06
Lead Sponsor
Price Vision Group
Target Recruit Count
510
Registration Number
NCT01143389
Locations
🇺🇸

Price Vision Group, Indianapolis, Indiana, United States

Cross Linking for Treatment of Corneal Infection

Not Applicable
Terminated
Conditions
Infectious Keratitis
Interventions
Device: UVX Light
First Posted Date
2009-06-03
Last Posted Date
2017-11-22
Lead Sponsor
Price Vision Group
Target Recruit Count
30
Registration Number
NCT00912509
Locations
🇺🇸

Price Vision Group, Indianapolis, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath